PEMF in Treating PTSD and Trauma: A New Trial

Written on 02/13/2024
PEMF Pharmacy

Study Overview

In an innovative approach to mental health treatment, a new clinical trial is exploring the potential of Pulsed Electromagnetic Fields (PEMF) therapy for individuals suffering from Post-Traumatic Stress Disorder (PTSD), complex PTSD (cPTSD), and trauma-related symptoms. This trial, utilizing low-voltage, direct current PEMF, aims to address both the physical and mental manifestations of trauma.

Brief Summary

The therapy employs PEMF devices, specifically the Scientific Consciousness Interface Operations (SCIO) device, which is recognized by various regulatory bodies including CE marking, ISO certification, and FDA classification as a Type II medical device. The SCIO device operates by measuring the patient's emitted frequencies as a form of Biofeedback, subsequently emitting corrective frequencies in various waveforms to counteract imbalances.

Detailed Description

The SCIO machine's technology is sophisticated, featuring AI to automatically adjust waveforms, frequencies, amperage, and voltage, with a cap at 5 Direct Current volts. The treatment involves placing electrodes on the patient's forehead, wrists, and ankles to both read and correct irregular frequencies through a process known as entrainment. A successful session is indicated by an entrainment efficiency of 85-100%.

Previous studies, such as one conducted by the University of Denmark, have highlighted the efficacy of similar electromagnetic therapies in treating conditions like treatment-resistant depression, further supporting the potential of PEMF therapy.

Trial Design

This pilot study is unique in its methodology, lacking a placebo group, a double-blind setup, and a control group. The primary objectives are to assess the effectiveness of a reduced session frequency and to evaluate the feasibility of scaling the treatment across multiple locations with minimal therapist training, thanks to the AI-assisted operation of the SCIO device.

Official Title and Criteria

Titled "Low-Voltage, Direct Current Pulsed ElectroMagnetic Field (PEMF) Therapy in Treating Patients With PTSD and cPTSD and Trauma," the study is open to individuals who can commit to six treatments over three weeks, provided they are not undergoing medication for severe psychotic conditions and are over 18 years of age.

PEMF Energetics

Complementing the clinical trial, the PEMF offers an accessible platform for individuals seeking relief from trauma, PTSD, and other mental health issues through PEMF therapy. This digital resource aims to broaden the availability of PEMF therapeutic techniques, promising a complementary approach to traditional mental health treatments.


This trial represents a significant step forward in the exploration of alternative treatments for PTSD and trauma-related conditions. By leveraging advanced technology and the therapeutic potential of PEMF, this study could pave the way for new, effective treatment modalities.

For more detailed information on this study, visit

To explore PEMF therapy for mental health issues further, visit PEMF